Pyrimidine substituted macrocyclic HCV inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8937080
SERIAL NO

12526553

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of the formula I:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • JANSSEN SCIENCES IRELAND UC;MEDIVIR AB;TIBOTEC PHARMACEUTICALS LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Belfrage, Anna Karin Gertrud Linnea Huddinge, SE 8 70
Classon, Björn Olof Huddinge, SE 3 31
Lindquist, Karin Charlotta Huddinge, SE 2 34
Nilsson, Karl Magnus Huddinge, SE 22 278
Raboisson, Pierre Jean-Marie Bernard Rosieres, BE 219 1747
Rosenquist, Åsa Annica Kristina Huddinge, SE 10 55
Samuelsson, Bertil Bengt Huddinge, SE 1 13
Wähling, Horst Jürgen Huddinge, SE 2 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 20, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00